Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance

被引:486
作者
Wells, AD
Li, XC
Li, YS
Walsh, MC
Zheng, XX
Wu, ZH
Nuñez, G
Tang, AM
Sayegh, M
Hancock, WW
Strom, TB
Turka, LA [1 ]
机构
[1] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[2] Harvard Univ, Sch Med, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[3] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
[4] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02142 USA
[5] LeukoSite Inc, Cambridge, MA 02142 USA
[6] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA
关键词
D O I
10.1038/15260
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanisms of allograft tolerance have been classified as deletion, anergy, ignorance and suppression/regulation. Deletion has been implicated in central tolerance(1), whereas peripheral tolerance has generally been ascribed to clonal anergy and/or active immunoregulatory states(2). Here, we used two distinct systems to assess the requirement for T-cell deletion in peripheral tolerance induction. in mice transgenic for Bcl-x(L), T cells were resistant to passive cell death through cytokine withdrawal, whereas T cells from interleukin-2-deficient mice did not undergo activation-induced cell death. Using either agents that block co-stimulatory pathways or the immunosuppressive drug rapamycin, which we have shown here blocks the proliferative component of interleukin-2 signaling but does not inhibit priming for activation-induced cell death, we found that mice with defective passive or active T-cell apoptotic pathways were resistant to induction of transplantation tolerance. Thus, deletion of activated T cells through activation-induced cell death or growth factor withdrawal seems necessary to achieve peripheral tolerance across major histocompatibility complex barriers.
引用
收藏
页码:1303 / 1307
页数:5
相关论文
共 24 条
[11]  
Li XC, 1998, J IMMUNOL, V161, P2241
[12]   INDUCTION BY ANTIGEN OF INTRATHYMIC APOPTOSIS OF CD4+CD8+TCRLO THYMOCYTES INVIVO [J].
MURPHY, KM ;
HEIMBERGER, AB ;
LOH, DY .
SCIENCE, 1990, 250 (4988) :1720-1723
[13]   The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry [J].
OReilly, LA ;
Huang, DCS ;
Strasser, A .
EMBO JOURNAL, 1996, 15 (24) :6979-6990
[14]   SURVIVAL OF MOUSE PANCREATIC-ISLET ALLOGRAFTS IN RECIPIENTS TREATED WITH ALLOGENEIC SMALL LYMPHOCYTES AND ANTIBODY TO CD40 LIGAND [J].
PARKER, DC ;
GREINER, DL ;
PHILLIPS, NE ;
APPEL, MC ;
STEELE, AW ;
DURIE, FH ;
NOELLE, RJ ;
MORDES, JP ;
ROSSINI, AA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (21) :9560-9564
[15]   RAPAMYCIN-INDUCED INHIBITION OF THE 70-KILODALTON S6 PROTEIN-KINASE [J].
PRICE, DJ ;
GROVE, JR ;
CALVO, V ;
AVRUCH, J ;
BIERER, BE .
SCIENCE, 1992, 257 (5072) :973-977
[16]   CD28-B7 BLOCKADE AFTER ALLOANTIGENIC CHALLENGE IN-VIVO INHIBITS TH1 CYTOKINES BUT SPARES TH2 [J].
SAYEGH, MH ;
AKALIN, E ;
HANCOCK, WW ;
RUSSELL, ME ;
CARPENTER, CB ;
LINSLEY, PS ;
TURKA, LA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (05) :1869-1874
[17]   ACQUISITION OF IMMUNOLOGICAL SELF-TOLERANCE [J].
SCHWARTZ, RH .
CELL, 1989, 57 (07) :1073-1081
[18]  
Sykes M, 1990, Semin Immunol, V2, P401
[19]   Modifications of CD8+ T cell function during in vivo memory or tolerance induction [J].
Tanchot, C ;
Guillaume, S ;
Delon, J ;
Bourgeois, C ;
Franzke, A ;
Sarukhan, A ;
Trautmann, A ;
Rocha, B .
IMMUNITY, 1998, 8 (05) :581-590
[20]  
Tran HM, 1997, J IMMUNOL, V159, P2232